• About
  • Privacy Policy
  • Terms
  • Contact
Friday, January 27, 2023
Financial Eye News
  • Home
  • Markets
    • Stock Market News
    • Commodities
    • Forex
    • Renewables
  • Cryptocurrency
    • Ultimate Guide to Crypto
  • Business
    • News
    • Companies
    • Technology
    • Climate
    • Politics
  • Reports
    • Ultimate Guide to Crypto
  • VideosNew
No Result
View All Result
  • Home
  • Markets
    • Stock Market News
    • Commodities
    • Forex
    • Renewables
  • Cryptocurrency
    • Ultimate Guide to Crypto
  • Business
    • News
    • Companies
    • Technology
    • Climate
    • Politics
  • Reports
    • Ultimate Guide to Crypto
  • VideosNew
No Result
View All Result
Financial Eye News
No Result
View All Result

Team behind Apple’s Face ID develops tiny robots to deliver drugs into brain

November 27, 2022
in Technology
Reading Time: 3 mins read
49 3
ADVERTISEMENT

The team behind Apple’s Face ID is developing tiny robots to deliver drugs into the brain, controlled by magnetic propulsion, to target hard to treat diseases.

Los Angeles-based Bionaut Labs raised $43.2mn in a second round of financing led by Khosla Ventures to fund the first clinical trials to try to prove that the robots are safe and effective.

Seven new investors, including Israel’s Deep Insight and Canada’s Sixty Degree Capital, joined the round.

The company is starting with trials to deliver drugs to treat a type of brain tumour and a rare paediatric neurological disorder Dandy-Walker Syndrome, where the robot will be used to poke a hole in a cyst.

It eventually hopes to address trickier and more common diseases such as Parkinson’s, Huntington’s, Alzheimer’s and strokes.

Michael Shpigelmacher, Bionaut’s chief executive, founded the company with Aviad Maizels because he wanted to do something “more meaningful” than consumer electronics. The pair co-founded PrimeSense, an Israeli 3D sensor company that they sold to Apple for about $400mn in 2013.

Shpigelmacher said the remote-controlled robots had the potential to become a “platform”, opening the way to treating diseases in the “holy grail” of the brain, across the central nervous system and beyond. The robots could also be used to diagnose disease by taking biopsies.

“There are so many places in the body where science today cannot reach easily,” he added.

The robots — a few millimetres long and containing a strong micro-magnet — would be injected at the back of the head. Then, using an external control system, it would be propelled by magnetic fields to the target area to release a drug and then return to the needle to be extracted.

Shpigelmacher said his “aha moment” came when he realised that even when we try to treat something very local, drugs were always distributed around the whole body, risking widespread side effects.

“That didn’t make sense to me as a roboticist. Robotics is all about accelerating the world around you in a precise manner,” he said.

The US Food and Drug Administration has granted Bionaut Labs a humanitarian use device designation and an orphan drug designation to accelerate its journey through clinical trials.

The company has done animal studies optimising the size and the speed of the mini-robots to try to ensure they do not damage tissues.

Iahn Cajigas González, a professor of neurosurgery at the University of Pennsylvania, said when he first heard about the device he was “incredulous” that it would actually work.

“My biggest concern when I hear of any technology is: is it going to be deployed safely? And everything that I saw when I visited their facilities shows that they really are very meticulous at every stage of the way. So I think it would fill a very important niche,” he said.

Samir Kaul, founding general partner at Khosla Ventures, said the long-term opportunity was “massive”.

He said Shpigelmacher was working closely with experts. But he added that it was an advantage that he did not have a background in medical science.

“Elon Musk wasn’t an auto executive, Brian Chesky didn’t come from Hilton, Travis Kalanick was not in taxi cabs. Sometimes big disruptions need to come from the outside,” he added.

Source: Financial Times

ADVERTISEMENT
Share6Tweet4Share1SendShareSend

Related Posts

Technology

French Pornhub case shows how hard it is to regulate the internet

December 5, 2022
Technology

Covid chaos at Foxconn iPhone plant causes 29% revenue fall

December 5, 2022
Technology

Spiracle is turning niche literary fiction into audiobooks

December 5, 2022
Technology

Elon Musk, Matt Taibbi, and a Very Modern Media Maelstrom

December 5, 2022
Technology

The apps making business more social

December 4, 2022
Technology

Meloni pushes back on Italy’s shift into digital payments age

December 4, 2022

Popular Stories

  • AIG to launch cut-price IPO of life and asset management unit

    48 shares
    Share 19 Tweet 12
  • EY boss targets $10bn boost from Silicon Valley tie-ups after break-up

    32 shares
    Share 13 Tweet 8
  • Tesla delays plan to restore Shanghai output to pre-lockdown levels -memo

    32 shares
    Share 13 Tweet 8
  • TV production giant Banijay to go public via Arnault-backed Spac

    30 shares
    Share 12 Tweet 8
  • Nio to Invest $32.8M Building R&D Labs in Shanghai By Financial Eye

    30 shares
    Share 12 Tweet 8
ADVERTISEMENT

Latest News

Taylor Swift Fans Sue Ticketmaster’s Parent Company

December 5, 2022

Fisker trades down following price cut at Citi By Financial Eye

December 5, 2022

UAW president faces run-off election as reformers make gains

December 5, 2022

Felipe Valls, 89, Whose Cuban Restaurant Became a Political Hub, Dies

December 5, 2022

Longroad buys 98-MW solar farm in California

December 5, 2022
Facebook Twitter LinkedIn

Financial Eye is one of the most trusted news sources for Financial News, global news and local USA news, we provide the news from the most trusted sources.

LEARN MORE »

Recent News

  • Taylor Swift Fans Sue Ticketmaster’s Parent Company
  • Fisker trades down following price cut at Citi By Financial Eye
  • UAW president faces run-off election as reformers make gains

Sections

  • Business
  • Climate
  • Commodities
  • Companies
  • Cryptocurrency
  • Cryptocurrency
  • Forex
  • Green Energy
  • Latest Financial News
  • News
  • Politics
  • Stock Market News
  • Technology
  • Videos

© 2022 Financial Eye News Media

No Result
View All Result
  • Home
  • Markets
    • Stock Market News
    • Commodities
    • Forex
    • Renewables
  • Cryptocurrency
    • Ultimate Guide to Crypto
  • Business
    • News
    • Companies
    • Technology
    • Climate
    • Politics
  • Reports
    • Ultimate Guide to Crypto
  • Videos

© 2022 Financial Eye News Media

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Subscribe To Our Daily News Round-Up.

The top ten most-read stories direct to your inbox

You have Successfully Subscribed!

You have Successfully Subscribed!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.